“…Furthermore, the ICA is claimed to be unaffected by changes in eye movements and sampling rate [ 27 ]. The ICA in particular has been used to investigate changes in cognitive workload in individuals at risk of cognitive impairment, including those with Parkinson’s disease, multiple sclerosis, and breast cancer [ 4 , 28 , 29 , 30 , 31 , 32 ]. Overall, the ICA seems to increase with cognitive demand, regardless of disease condition [ 29 ].…”